Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
| Metric | DBD | RH |
|---|---|---|
| Price | $65.63 | $117.45 |
| Change today | ▲ 2.92% | ▼ 2.50% |
| Market cap | $2.23B | $2.22B |
| Return, 3 months | – | – |
| Return, year to date | – | – |
| Return, 1 year | – | – |
| P/E (TTM) | 21.7 | 20.8 |
| P/B | 2.3 | 18.5 |
| P/E percentile vs own 5y | – | – |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | – | – |
| Net profit growth (YoY) | – | – |
| Gross margin | – | – |
| Operating margin | – | – |
| Net margin | – | – |
| Return on equity | – | – |
| Analyst target vs. price | +52.4% | +45.4% |
| Analyst buy share | 100% | 38% |
| RSI (14) | – | – |
| 30-day volatility | – | – |
| Max drawdown, 1 year | – | – |
| Trend read | – | – |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
